Award

A subunit Cryptococcus vaccine

Description: Project Narrative Cryptococcosis, due to infection by the encapsulated yeasts C. neoformans and C. gattii, is the most common etiological agent of culture-positive meningitis. Nearly 200,000 people, most of whom are HIV-infected, die from this disease annually. The proposed research addresses a global public health need for a cryptococcal vaccine by using carefully designed mouse and human studies to develop a subunit multiantigen vaccine suitable for eventual human testing.
Funding type: research
Funder scheme: R01
Start date: 2022-07-21
End date: 2027-06-30
Investigator: STUART MICHAEL LEVITZ
Institution: UNIV OF MASSACHUSETTS MED SCH WORCESTER
Funded outputs count: 18
Funder award ID: R01AI172154
OpenAlex ID: G9000856445
2026 · Satya Ranjan Sahu, Charles A. Specht, et al. · PLoS Pathogens · 3
2024 · Maureen M. Hester, Diana Carlson, et al. · Frontiers in Immunology · 8
2024 · Charles A. Specht, Woei C. Lam, et al. · Methods in molecular biology · 4
2023 · Ernesto R. Soto, Charles A. Specht, et al. · Pharmaceutics · 7
2023 · Ernesto R. Soto, Charles A. Specht, et al. · Journal of Controlled Release · 20
2023 · Poppy Sephton-Clark, Scott A. McConnell, et al. · Proceedings of the National Academy of Sciences · 20
2022 · Therese Woodring, George S. Deepe, et al. · Seminars in Immunology · 8
Year
Topic